METAVIA INC. Tax Withholding Paid on Stock Awards
METAVIA INC. (MTVA) reported Tax Withholding Paid on Stock Awards of $12.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-06
- METAVIA INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- METAVIA INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $0.00.
- METAVIA INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-06-30 was $0.00.
- METAVIA INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-03-31 was $12.00K.
- METAVIA INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $12.00K, a 75.00% decline from fiscal 2024.
- METAVIA INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $48.00K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $12.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $12.00K 10-Q · filed 2025-11-06 | $19.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $12.00K 10-Q · filed 2026-08-06 | $19.00K derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-03-31 | $12.00K 10-Q · filed 2026-05-14 | $19.00K derived: sum of 2 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $48.00K 10-K · filed 2026-03-26 | ||
| 2024-09-30 | $41.00K 10-Q · filed 2025-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |